HomeCONCORDBIO • NSE
add
Concord Biotech Ltd
Previous close
₹2,327.40
Day range
₹2,215.10 - ₹2,357.40
Year range
₹1,327.05 - ₹2,664.00
Market cap
236.35B INR
Avg Volume
147.02K
P/E ratio
61.00
Dividend yield
0.39%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.10B | 18.23% |
Operating expense | 1.10B | 6.68% |
Net income | 957.41M | 18.17% |
Net profit margin | 30.87 | -0.03% |
Earnings per share | 9.15 | 18.22% |
EBITDA | 1.37B | 14.74% |
Effective tax rate | 26.54% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.84B | 26.07% |
Total assets | 17.64B | 13.75% |
Total liabilities | 1.74B | -11.57% |
Total equity | 15.90B | — |
Shares outstanding | 104.63M | — |
Price to book | 15.31 | — |
Return on assets | — | — |
Return on capital | 19.71% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 957.41M | 18.17% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Founded
2000
Website
Employees
1,377
